Literature DB >> 33670221

TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense.

Ling Wang1,2, Shunbin Ning1,2.   

Abstract

The tripartite motif (TRIM) family comprises at least 80 members in humans, with most having ubiquitin or SUMO E3 ligase activity conferred by their N-terminal RING domain. TRIMs regulate a wide range of processes in ubiquitination- or sumoylation-dependent manners in most cases, and fewer as adaptors. Their roles in the regulation of viral infections, autophagy, cell cycle progression, DNA damage and other stress responses, and carcinogenesis are being increasingly appreciated, and their E3 ligase activities are attractive targets for developing specific immunotherapeutic strategies for immune diseases and cancers. Given their importance in antiviral immune response, viruses have evolved sophisticated immune escape strategies to subvert TRIM-mediated mechanisms. In this review, we focus on their regulation of IFN-I-mediated innate immune response, which plays key roles in antiviral and antitumor defense.

Entities:  

Keywords:  IFN-I; IRFs; PRR; TRIMs; ubiquitination

Mesh:

Substances:

Year:  2021        PMID: 33670221      PMCID: PMC7916971          DOI: 10.3390/v13020279

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.818


  237 in total

Review 1.  Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system.

Authors:  Maria G Masucci
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

Review 2.  Ubiquitination and SUMOylation in the chronic inflammatory tumor microenvironment.

Authors:  Shu Chun Chang; Jeak Ling Ding
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-08-21       Impact factor: 10.680

Review 3.  Fine-tuning of antiviral innate immunity by ubiquitination.

Authors:  Yi Zheng; Chengjiang Gao
Journal:  Adv Immunol       Date:  2019-12-09       Impact factor: 3.543

4.  TRIM14 Is a Key Regulator of the Type I IFN Response during Mycobacterium tuberculosis Infection.

Authors:  Caitlyn T Hoffpauir; Samantha L Bell; Kelsi O West; Tao Jing; Allison R Wagner; Sylvia Torres-Odio; Jeffery S Cox; A Phillip West; Pingwei Li; Kristin L Patrick; Robert O Watson
Journal:  J Immunol       Date:  2020-05-13       Impact factor: 5.422

5.  Tripartite motif proteins: an emerging antiviral protein family.

Authors:  Girish Patil; Shitao Li
Journal:  Future Virol       Date:  2019-01-21       Impact factor: 1.831

6.  Ubiquitination of TLR3 by TRIM3 signals its ESCRT-mediated trafficking to the endolysosomes for innate antiviral response.

Authors:  Wei-Wei Li; Ying Nie; Yan Yang; Yong Ran; Wei-Wei Luo; Mei-Guang Xiong; Su-Yun Wang; Zhi-Sheng Xu; Yan-Yi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-02       Impact factor: 11.205

Review 7.  Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation.

Authors:  Nina Germic; Ziva Frangez; Shida Yousefi; Hans-Uwe Simon
Journal:  Cell Death Differ       Date:  2019-02-08       Impact factor: 15.828

Review 8.  The TRIMendous Role of TRIMs in Virus-Host Interactions.

Authors:  Sarah van Tol; Adam Hage; Maria Isabel Giraldo; Preeti Bharaj; Ricardo Rajsbaum
Journal:  Vaccines (Basel)       Date:  2017-08-22

9.  HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection.

Authors:  Chiranjeevi Bodda; Line S Reinert; Stefanie Fruhwürth; Timmy Richardo; Chenglong Sun; Bao-Cun Zhang; Maria Kalamvoki; Anja Pohlmann; Trine H Mogensen; Petra Bergström; Lotta Agholme; Peter O'Hare; Beate Sodeik; Mads Gyrd-Hansen; Henrik Zetterberg; Søren R Paludan
Journal:  J Exp Med       Date:  2020-07-06       Impact factor: 14.307

Review 10.  PML and PML nuclear bodies: implications in antiviral defence.

Authors:  Roger D Everett; Mounira K Chelbi-Alix
Journal:  Biochimie       Date:  2007-01-27       Impact factor: 4.079

View more
  2 in total

Review 1.  TRIM family contribute to tumorigenesis, cancer development, and drug resistance.

Authors:  Ning Huang; Xiaolin Sun; Peng Li; Xin Liu; Xuemei Zhang; Qian Chen; Hong Xin
Journal:  Exp Hematol Oncol       Date:  2022-10-19

Review 2.  Role of HLA-G in Viral Infections.

Authors:  Simon Jasinski-Bergner; Dominik Schmiedel; Ofer Mandelboim; Barbara Seliger
Journal:  Front Immunol       Date:  2022-02-14       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.